Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5
Methods Randomised, double‐blind, multicentre trial. Random number generation done centrally, double‐blinded by use of identical placebos
Participants 100 healthy women recruited in the study from Henan Research Institute for family planning
Included women with regular menstrual periods, who had had a single act of unprotected intercourse or had had multi‐intercourse but attended the clinic within 72 h of the first one
Excluded women who were breastfeeding, on hormonal contraception in the current cycle and those with uncertain dates of last menstrual period
Interventions Mife (single dose) 10 mg vs LNG 0.75 mg, 2 doses, 12 h apart, orally
Outcomes Observed number of pregnancies, side effects and changes in menstrual pattern
Notes
  1. Loss to follow‐up: Mife 2 women; LNG 2 women

  2. Observed pregnancy/expected pregnancy/total number of women: Mife 0/4/48; LNG 2/4/48

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random number generation done centrally
Allocation concealment (selection bias) Low risk Randomised, double‐blind, multicentre trial. Random number generation done centrally, double‐blinded by use of identical placebos
Blinding (performance bias and detection bias) All outcomes Low risk Double‐blind
Incomplete outcome data (attrition bias) All outcomes Low risk Loss to follow‐up reported
Selective reporting (reporting bias) Low risk Reported planned outcomes
Other bias Low risk None detected